Login Contact Us
Oct 2017, Vol 5, Issue 4
Advanced Search
Title
Authors
Keyword
Poll
How do you find the scientific quality of the published articles on our web site?
Original Article
Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients
Farnaz Shokri, Parvin Mostafa Gharebaghi, Ali Esfahani, Manizheh Sayyah-Melli, Mehri Jafari Shobeiri, Elaheh Ouladsahebmadarek, Morteza Ghojazadeh
Women?s Reproductive Health Research Center, Tabriz university of Medical sciences, Tabriz, Iran

IJWHR 2017; 5: 324-331
DOI: 10.15296/ijwhr.2017.55
Viewed : 5545 times
Downloaded : 6611 times.

Keywords : Ovarian Cancer, Ginger, Chemotherapy, Outcome
Full Text(PDF) | Related Articles
Abstract
Objectives: The principal treatment of ovarian cancer is surgery with or without chemotherapy. The chemotherapy, however, might be ineffective and long with serious side-effects. To obviate these shortcomings, more efficient and safer medications are required, among which ginger has recently gained popularity because of its anti-cancer properties. This study aims to compare outcomes and side-effects of adjuvant chemotherapy with and without ginger in ovarian cancer patients.

Materials and Methods: A total of 49 patients (20 patients in case group and 29 patients in control group) with stage I to III, histopathologically proved ovarian cancer underwent cytoreductive surgery followed by platinum-based adjuvant chemotherapy with and without investigator-prepared oral ginger capsules (2 g per day for 6 cycles). Potential side-effects, poor 12-month outcome (serum CA125 levels >35U, radiologic evidence of metastasis and recurrence, or death), and 12-month disease-free survival were documented and compared between the 2 groups.

Results: Poor outcome including serum CA125>35, metastasis, recurrence or death was documented more common in control group (69% versus 40%). metastasis frequency confirmed by computerized tomography (CT) scan 6 month after treatment was significantly lower in case group (P = 0.04). There was no significant difference regarding mortality and disease free survival during one year follow-up after treatment between 2 groups (P = 0.55). Chemotherapy complications such as nausea, vomiting, weight loss, and peripheral neuropathy were detected in case group less than control group but the difference was not significant.

Conclusion: Oral administration of ginger is along with a significantly better 12-month outcome in patients on chemotherapy because of ovarian cancer, and accordingly, considering its safety, its administration is recommended.

Cite By, Google Scholar

Google Scholar

Articles by Shokri F
Articles by Esfahani A
Articles by Sayyah-melli M
Articles by Jafari Shobeiri M
Articles by Ghojazadeh M

PubMed

Articles by Farnaz Shokri
Articles by Ali Esfahani
Articles by Morteza Ghojazadeh

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics